|Bid||2.6200 x 1100|
|Ask||3.1500 x 900|
|Day's range||2.6800 - 3.0000|
|52-week range||1.2500 - 4.4700|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||9.29|
Whilst it may not be a huge deal, we thought it was good to see that the Compass Therapeutics, Inc. ( NASDAQ:CMPX...
If you want to know who really controls Compass Therapeutics, Inc. ( NASDAQ:CMPX ), then you'll have to look at the...
BOSTON, January 07, 2022--Compass Therapeutics, Inc. (Nasdaq: CMPX) will present a company update at the 40th Annual J.P. Morgan Healthcare Conference on Wed., Jan. 12, 2022.